Richard A. Colvin, Chief Medical Officer at bluebird bio, Inc. (BLUE), sold 19 shares at $9.24 ($176) on 2025-01-06, disclosed to the SEC on 2025-01-08.
Open-market sale of $176 BLUE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BLUE | SELL | 2024-12-12 | $1K | — | Filing → |
| BLUE | SELL | 2024-03-05 | $10K | — | Filing → |
| BLUE | SELL | 2024-01-09 | $848 | — | Filing → |